660 results on '"Sugimura, Yoshiki"'
Search Results
2. Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure
3. First-in-human phase I clinical trial of the NY-ESO-1 protein cancer vaccine with NOD2 and TLR9 stimulants in patients with NY-ESO-1-expressing refractory solid tumors
4. The usefulness of the maximum Hounsfield units (HU) in predicting the shockwave lithotripsy outcome for ureteral stones and the proposal of novel indicators using the maximum HU
5. Castration-induced stromal remodeling disrupts the reconstituted prostate epithelial structure
6. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells
7. The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA)
8. Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer
9. CT-Guided Percutaneous Cryoablation in Renal Cell Carcinoma: Factors Affecting Local Tumor Control
10. Combination treatment with naftopidil increases the efficacy of radiotherapy in PC-3 human prostate cancer cells
11. Initial Experience of Photodynamic Diagnosis-Assisted Transurethral Resection of Bladder Tumor (PDD-TURBT)
12. Manserin as a novel histochemical neuroendocrine marker in prostate cancer
13. Identification of a new pharmacological activity of the phenylpiperazine derivative naftopidil: tubulin-binding drug
14. Radiofrequency ablation for the treatment of recurrent bone and soft-tissue sarcomas in non-surgical candidates
15. Neoajuvant Chemotherapy with Gemcitabine and Cisplatin Plus S-1 for Primary Female Urethral Adenocarcinoma
16. THE EXPLORATION OF THE ORDER IN THE HETEROGENEITY OF PROSTATE CANCER-ASSOCIATED STROMA ENVIRONMENT.: MP62-16
17. A NEW INSIGHT OF CELL-CELL INTERACTIONS IN TUMOR STROMA OF PROSTATE CANCER: MP62-17
18. FIBROBLASTS PROLONG SERUM PROSTATE-SPECIFIC ANTIGEN DECLINE AFTER ANDROGEN DEPRIVATION THERAPY IN PROSTATE CANCER: MP62-15
19. PHASE I CLINICAL STUDY ON THE COMBINATION THERAPY OF CHP-NY-ESO-1 CANCER VACCINE AND MIS416 FOR THE TREATMENT OF PATIENTS WITH NY-ESO-1 EXPRESSING REFRACTORY UROTHELIAL CANCER OR CASTRATION-RESISTANT PROSTATE CANCER: PD32-05
20. PROSTATE-SPECIFIC ANTIGEN DENSITY IS THE MOST APPROPRIATE FACTOR FOR DETECTING UNFAVORABLE PATHOLOGY AFTER RADICAL PROSTATECTOMY IN MEN ELIGIBLE FOR ACTIVE SURVEILLANCE FROM MUTLI-INSTITUTIONAL STUDY: MP57-08
21. Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer
22. MP35-15 PRETHERAPEUTIC PLASMA FIBRINOGEN LEVEL IS AN INDEPENDENT SURVIVAL PREDICTOR IN RENAL CELL CARCINOMA
23. A case of adenocarcinoma of the rete testis with durable response to cisplatin‐based chemotherapy
24. Neoadjuvant Chemohormonal Therapy before Radical Prostatectomy for Japanese Patients with High-Risk Localized Prostate Cancer
25. Androgen receptor W741C and T877A mutations in AIDL cells, an androgen-independent subline of prostate cancer LNCaP cells
26. Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results
27. A case of local advanced penile cancer treated with multimodality therapy
28. Third-line gemcitabine monotherapy for platinum-resistant advanced urothelial cancer
29. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma
30. Structural changes in α1-adrenoceptor antagonist-treated human prostatic stroma
31. Essential Roles of Epithelial Bone Morphogenetic Protein Signaling During Prostatic Development
32. A case of IgG4-positive plasma cell-rich tubulointerstitial nephritis in a kidney allograft mimicking IgG4-related kidney disease
33. FIBROBLASTS IN PROSTATE CANCER MICROENVIRONMENT PRESCRIBE SERUM PROSTATE-SPECIFIC ANTIGEN KINETICS AFTER HORMONE THERAPY: MP49-16
34. DEVELOPMENT OF AN EFFICIENT BLADDER TUMOR MODEL BY RECOMBINING WITH MESENCHYMAL CELLS: MP21-10
35. Intermittent docetaxel therapy with estramustine for hormone-refractory prostate cancer in Japanese patients
36. Small cell carcinoma of the prostate treated with amrubicin
37. Heterogeneous induction of an invasive phenotype in prostate cancer cells by coculturing with patient‐derived fibroblasts
38. Role of stromal tenascin-C in mouse prostatic development and epithelial cell differentiation
39. Intracellular localization of protein C inhibitor (PCI) and urinary plasminogen activator in renal tubular epithelial cells from humans and human PCI gene transgenic mice
40. Correlation between ZIP2 messenger RNA expression and zinc level in rat lateral prostate
41. Radiofrequency Ablation Combined with Renal Arterial Embolization for the Treatment of Unresectable Renal Cell Carcinoma Larger Than 3.5 cm: Initial Experience
42. Image-Guided Radiofrequency Ablation for Adrenocortical Adenoma with Cushing Syndrome: Outcomes After Mean Follow-up of 33 Months
43. Temporary decrease in tacrolimus clearance in cytochrome P450 3A5 non‐expressors early after living donor kidney transplantation: Effect of interleukin 6–induced suppression of the cytochrome P450 3A gene
44. Low incidence of benign lesions in resected suspicious renal masses greater than 2 cm: Single-center experience from Japan
45. The Long-term Results with Delayed-combined Androgen Blockade Therapy in Local or Locally Advanced Prostate Cancer
46. PEDICLED VASTUS LATERALIS MUSCULOFASCIAL FLAP AS A NEW TECHNIQUE FOR REPAIRING RECTOURETHRAL FISTULA AFTER RADICAL PROSTATECTOMY
47. Epithelial Bmp (Bone morphogenetic protein) signaling for bulbourethral gland development: A mouse model for congenital cystic dilation
48. Abstract 3983: Direct contact of heterogeneous fibroblasts with cancer cells regulates the invasive phenotype of prostate cancer cells
49. A Kidney Transplant Recipient with Recurrent Henoch-Schönlein Purpura Nephritis Successfully Treated with Steroid Pulse Therapy and Epipharyngeal Abrasive Therapy
50. LEIOMYOSARCOMA ARISING FROM THE RENAL VEIN
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.